2024
E. Meto, H. Rosay, F. Espinasse, AS. Lot, M. El Hajjam, S. Gnamien Clermont, R. Launois – ISPOR Europe 2024 : Budget impact analysis of Midline, Short Peripheral and
PICC catheters for peripheral intravenous infusions
E. Meto, JM. Grosbois, R. Launois – ISPOR Europe 2024 : Effectiveness of a hybrid home-based pulmonary
rehabilitation program for patient with COPD
E. Meto, TN. Willig, R. Launois – ISPOR Europe 2024 : Effectiveness of an integrated care model for children
with Learning and Language Disorders (LLD)
E. Meto, N. Biard, R. Launois- ISPOR Europe 2024 : Effectiveness of Support Services on the Use of
Assistive Technologies
2022
E. Meto, E.Cabout, S. Gnamien-Clermont, F. Espinasse, AS. Lot, R. Launois
EUROPHARMAT 2022 ;
Midlines vs Catheters veineux périphériques courts et PICCS : Impact budgéaire
R. Launois, E. Cabout, D. Benamouzig, L. Velpry, E. Meto, K. Briot, F. Alliot, L. Perrin, L. Grange, R. Sellami, C. Touboul A. Crochard, C. Roux
AFCRO 2022 ;
Freins et levier de la mise en place d’une politique de prévention secondaire de l’ostéoporose : Etude Effel
2021
E. Cabout, S. Eymere, R. Launois,
ISPOR 2021 ;
Cost-effectiveness analysis of community-based HIV care strategies
E. Cabout, S. Eymere, R. Launois,
ISPOR 2021 ;
Analysis of the economic consequences of the evolution of the community-based HIV care model in Mali
R. Launois, E. Cabout, D. Benamouzig, L. Velpry, K. Briot, F. Alliot, Laure Perrin, L. Grange, R. Sellami, C. Touboul, A. Crochard, C. Roux, ISPOR 2021 ;
Barriers and expectations for patients in post-osteoporotic fractures care in France: the EFFEL Study
E. Cabout, G. Huguel, S. Eymere, R. Launois, ISPOR 2021 ;
Impact of antidiabetic treatment on renal function in diabetics with chronic renal failure
S. Eymere, E. Cabout, G. Boy G. Chales, L. Grange, C. Sebire, A. Le Chevalier, F. Alliot Launois, ISPOR 2021 ;
Speak up your pain : Patient Care Course In Chronic Pain
2020
E. Cabout, R. Launois, ISPOR 2020;
Assessing Partionned Survival Model in Cancer Treatment Evaluation in France
E. Cabout, S. Eymere, R. Launois, S. Seite, C. Taieb ISPOR 2020;
Cost-Effectiveness of Emollients in the French Setting
E. Cabout, R. Launois, ISPOR 2020;
Impact of cancer – productivity of a company
Eymere S, E. Cabout, R. Launois, G. Boy, G. Chales, C. Sebire, L. Grange, A. Le Chevalier, F. Alliot-Launois
SFETD – 2020 ;
Douleurs Chroniques : enquête sur la perception des malades Parlez de vos douleurs
E. Cabout, S. Eymere, R. Launois, C. Taieb, S. Seite ;
JDP – 2020;
Etude coût-efficacité de différents émollients pour le traitement de patients français souffrant de dermatite atopique;
S. Eymere, E. Cabout, R. Launois ISPOR 2020;
Drug Prescription in Diabetic Kidney Disease, a Case in Individualized Medicin
2019
2018
R. Launois, K. Ezzedine, E. Cabout, Z. Reguai, S. Merrahand, S. Heas, J. Seneschal, L. Misery, C. Taieb ; ISPOR Europe 2018;
Importance of the out-of-pocket cost for adult patients with atopic dermatitis
J-B. Trouiller, E. Cabout, R. Launois,
ISPOR 2018
Evaluation of The Recommandations Complicance on the Diabetic Nephropathy Management in France : The ND-CRIS Cohort
E. Cabout, R. Launois, ISPOR 2018
Analysis of the Analytical and Methodological Framework of the Health Economic Evaluation Assessments Delivered in France
Mapping the SF-36 to the EQ-5D-3L in Randomized Trial : The EMOCAR Study
2017
E. Cabout, A. Kabeshova, R. Launois,
Ispor Europe 2017,
Economic Evaluation of Cerebral Oxymetry Monitoring in Carotid Endartectomy : the EMOCAR Randomized Controlled Trial
A. Kabeshova, S. Ben Hariz, E. Tsakeu, R. Benamouzig, R. Launois;
ISPOR 2017;
Cost-Effectiveness Analysis of Rifaximin-Lamba Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France